Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma

Summary

The objective of the present trial is to evaluate the local and general safety of the intratumoural electrotransfer of increasing doses of Plasmid AMEP in patients suffering from advanced or metastatic melanoma and to identify doses that could be effective on cutaneous lesions in man.

Timeline

Start

2010-07

Primary completion

2012-06

Completion

2013-01

Outcome

Outcome not reported

Stopped: “The study has been halted due to the low enrolment rate.”

Drugs

Indications